Projects per year
Personal profile
Education
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
An Investigation into the Role of Innate-Like Cd8+T Cells Underlying the Responses to Immunotherapy in Hcc Patients
Teng, W. (PI), Lin, C.-Y. (CoPI) & Liu, H. (CoPI)
01/08/25 → 31/07/26
Project: National Science and Technology Council › National Science and Technology Council Academic Grants
-
Utilizing Multi-Omics Approach to Investigate the Association between Hbv Quasispecies and Host Antiviral Immune Phenotype Along with Their Impacts on Clinical Outcome and Treatment Efficacy
Jeng, W.-J. (PI), Huang, C. H. (CoPI), Lin, C.-Y. (CoPI), Lin, P. T. (CoPI), Teng, W. (CoPI) & Yang, H. I. (CoPI)
01/08/24 → 31/07/25
Project: National Science and Technology Council › National Science and Technology Council Academic Grants
-
An Investigation into the Role and Underlying Mechanisms of Innate-Like T Cells in Hcc Patients Receiving Immune Checkpoint Inhibitors by Single Cell Approach
Teng, W. (PI) & Lin, C.-Y. (CoPI)
01/08/24 → 31/07/25
Project: National Science and Technology Council › National Science and Technology Council Academic Grants
-
Baseline serum EV-miR-1-3p as a protective factor and biomarker for hepatocellular carcinoma development after HCV eradication
Teng, W., Ku, W. T., Lin, P. T., Chen, G. T., Chu, L. C. J., Liu, H., Lin, Y. C. & Lin, C. Y., 01 07 2025, In: Journal of Translational Medicine. 23, 1, p. 722 722.Research output: Contribution to journal › Journal Article › peer-review
Open Access1 Scopus citations -
Combination of Hepatic Arterial Infusion Chemotherapy with Tyrosine Kinase Inhibitor Provides Better Survival in Advanced Hepatocellular Carcinoma Patients
Liu, C. W., Lin, P. T., Teng, W., Chen, W. T., Su, C. W., Hsieh, Y. C., Lin, C. C., Lin, C. Y. & Lin, S. M., 2025, In: Journal of Hepatocellular Carcinoma. 12, p. 1017-1029 13 p.Research output: Contribution to journal › Journal Article › peer-review
Open Access -
Hepatocellular carcinoma systemic treatment update: From early to advanced stage
Teng, W., Wu, T. C. & Lin, S. M., 08 2025, In: Biomedical Journal. 48, 4, p. 100815 100815.Research output: Contribution to journal › Review article › peer-review
Open Access3 Scopus citations -
Letter to the Editor: Peripheral Foxp3-high Tregs as a dual biomarker for HCC prognosis and Immunotherapy response
Huang, C. H., Ku, W. T., Teng, W., Jeng, W. J. & Lin, C. Y., 2025, (Accepted/In press) In: Hepatology.Research output: Contribution to journal › Journal Letter › peer-review
1 Scopus citations -
Moderate Immune-Related Liver Injury Is a Good Factor in Patients with Hepatoma Under Atezolizumab Plus Bevacizumab
Wu, T. C., Lin, P. T., Teng, W., Shen, E. Y. L., Su, C. W., Hsieh, Y. C., Chen, W. T., Wu, T. H., Lin, C. C., Lin, S. M. & Lin, C. Y., 28 09 2025, In: Cancers. 17, 19, 3157.Research output: Contribution to journal › Journal Article › peer-review
Open Access